Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Robot-Assisted Gait Training vs Visual Feedback Balance Training in Stroke

2 novembre 2026 mis à jour par: Yakup Erden, MD, Abant Izzet Baysal University

Comparaison de l'entraînement à la marche assisté par robot et de l'entraînement à l'équilibre avec rétroaction visuelle sur les résultats d'équilibre et de marche chez les patients victimes d'un AVC

Stroke frequently leads to balance impairment and gait dysfunction, increasing fall risk and limiting functional independence. Technology-assisted rehabilitation approaches such as robot-assisted gait training and visual feedback balance training have been shown to improve balance and mobility in stroke patients.

This randomized, assessor-blinded clinical trial aims to compare the effects of robot-assisted gait training and visual feedback balance training on balance and gait outcomes in patients with subacute and chronic stroke. Both interventions are part of routine clinical rehabilitation practice. Participants will be evaluated at baseline and after 4 weeks of intervention using clinical balance, gait, and functional assessments.

Aperçu de l'étude

Description détaillée

Stroke is a leading cause of neurological disability worldwide and is frequently associated with gait disturbances and impaired balance. Approximately 80% of stroke survivors experience walking limitations, and many are at increased risk of falls due to postural instability. Restoring balance and independent ambulation is therefore a primary goal of stroke rehabilitation.

Technology-assisted rehabilitation approaches have been increasingly integrated into clinical practice. Robot-assisted gait training provides repetitive, task-specific, and controlled gait patterns that may enhance motor relearning and postural control. Visual feedback balance training using computerized posturography systems aims to improve weight shifting, postural stability, and dynamic balance through real-time feedback.

Although both interventions have demonstrated beneficial effects when combined with conventional rehabilitation, direct comparisons between these two technology-based approaches under similar treatment dosage conditions are limited.

This prospective, randomized, assessor-blinded clinical trial will compare robot-assisted gait training and visual feedback balance training in subacute and chronic stroke patients receiving inpatient rehabilitation. Both interventions are routinely applied in the clinical setting, and no additional experimental procedures will be introduced.

Participants will receive 4 weeks of intervention. Outcomes will be assessed at baseline and after treatment using the Berg Balance Scale as the primary outcome measure, along with secondary measures including functional mobility, gait speed, motor recovery, fear of falling, functional independence, and posturography-derived balance parameters.

Type d'étude

Interventionnel

Inscription (Réel)

50

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Bolu, Turquie (Türkiye)
        • AIBU Izzet Baysak Physical Treatment and Rehabilitation Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

21 ans à 85 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Age 21-85 years
  • Diagnosis of ischemic or hemorrhagic stroke confirmed by clinical and radiological findings
  • Functional Ambulation Category (FAC) ≥ 3
  • Modified Ashworth Scale ≤ 2 (lower extremity)
  • Ability to understand and follow simple verbal instructions
  • Mini-Mental State Examination (MMSE) score ≥ 23

Exclusion Criteria:

  • Unstable cardiopulmonary conditions
  • Severe musculoskeletal disorders affecting standing or walking
  • Severe aphasia preventing participation in assessments
  • Severe visual impairment interfering with balance testing

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Robot-Assisted Gait Training Group

Robot-Assisted Gait Training Conventional Rehabilitation Program

Robot-Assisted Gait Training (RoboGait®) Robot-assisted gait training will be delivered using the RoboGait® device (Bama Technology, METU Technokent, Ankara, Türkiye). The system provides repetitive, task-specific gait training with controlled movement patterns to improve dynamic balance, gait symmetry, and motor relearning. Sessions will be performed twice weekly for 4 weeks, each lasting 30 minutes. Body weight support and gait parameters will be adjusted according to the patient's clinical status and tolerance.

Other: Conventional Rehabilitation Program All participants will receive conventional rehabilitation for 40 minutes per session, 5 days per week for 4 weeks. The program includes static and dynamic balance exercises, lower extremity and trunk strengthening, weight shifting, sit-to-stand training, turning activities, and gait-related balance exercises under therapist supervision. Exercise progression will be individualized based on functional capacity and safety.

Comparateur actif: Visual Feedback Balance Training Group

Visual Feedback Balance Training Conventional Rehabilitation Program

Visual Feedback Balance Training Visual feedback balance training will be performed using the ProKin 252 system (TecnoBody S.R.L., Bergamo, Italy). The system provides real-time visual feedback to improve postural stability, weight shifting, and dynamic balance control. Sessions will be conducted twice weekly for 4 weeks, each lasting 30 minutes. Training difficulty will be progressively adjusted according to patient performance and safety.

Other: Conventional Rehabilitation Program All participants will receive conventional rehabilitation for 40 minutes per session, 5 days per week for 4 weeks. The program includes static and dynamic balance exercises, lower extremity and trunk strengthening, weight shifting, sit-to-stand training, turning activities, and gait-related balance exercises under therapist supervision. Exercise progression will be individualized based on functional capacity and safety.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Berg Balance Scale
Délai: Before Treatment

The BBS is used to objectively determine a patient's ability to balance safely during a predetermined set of tasks. The scale comprises 14 items. Each item receives a score ranging from 0 to 4, which is a five-point rank scale with 0 indicating the lowest level of functioning and 4 indicating the highest level of functioning.

Before Treatment
Berg Balance Scale
Délai: 4 Week After Treatment

The BBS is used to objectively determine a patient's ability to balance safely during a predetermined set of tasks. The scale comprises 14 items. Each item receives a score ranging from 0 to 4, which is a five-point rank scale with 0 indicating the lowest level of functioning and 4 indicating the highest level of functioning.

4 Week After Treatment

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Timed Up and Go Test
Délai: Before Treatment

The Timed Up and Go Test assesses functional mobility and dynamic balance. Participants are instructed to stand up from a chair, walk 3 meters, turn, walk back, and sit down. The time required to complete the task is recorded in seconds.

Before Treatment
Timed Up and Go Test
Délai: 4 Week After Treatment

The Timed Up and Go Test assesses functional mobility and dynamic balance. Participants are instructed to stand up from a chair, walk 3 meters, turn, walk back, and sit down. The time required to complete the task is recorded in seconds.

4 Week After Treatment
10-Meter Walk Test
Délai: Before Treatment

The 10-Meter Walk Test assesses gait speed over a short distance. Participants are instructed to walk 10 meters at a comfortable pace, and walking speed is calculated based on the time required to complete the distance. Higher walking speed reflects better gait performance.

Before Treatment
10-Meter Walk Test
Délai: 4 Week After Treatment

The 10-Meter Walk Test assesses gait speed over a short distance. Participants are instructed to walk 10 meters at a comfortable pace, and walking speed is calculated based on the time required to complete the distance. Higher walking speed reflects better gait performance.

4 Week After Treatment
Fugl-Meyer Assessment - Lower Extremity
Délai: Before Treatment

The Fugl-Meyer Assessment for the lower extremity evaluates motor impairment following stroke, including reflex activity, movement synergies, coordination, and voluntary movement control.Each item is scored with a 3-point ordinal scale (0: unable at all, 1: partially able, 2: fully able). Higher total scores reflect better lower limb motor function.

Before Treatment
Fugl-Meyer Assessment - Lower Extremity
Délai: 4 Week After Treatment

The Fugl-Meyer Assessment for the lower extremity evaluates motor impairment following stroke, including reflex activity, movement synergies, coordination, and voluntary movement control.Each item is scored with a 3-point ordinal scale (0: unable at all, 1: partially able, 2: fully able). Higher total scores reflect better lower limb motor function.

4 Week After Treatment
Barthel Index
Délai: Before Treatment

The Barthel Index measures functional independence in activities of daily living, including mobility, transfers, feeding, dressing, and personal care. Scores range from 0 to 100, with higher scores indicating greater independence.

Before Treatment
Barthel Index
Délai: 4 Week After Treatment

The Barthel Index measures functional independence in activities of daily living, including mobility, transfers, feeding, dressing, and personal care. Scores range from 0 to 100, with higher scores indicating greater independence.

4 Week After Treatment
Falls Efficacy Scale - International
Délai: Before Treatment

The Falls Efficacy Scale-International assesses concern about falling during daily activities. The scale consists of 16 items rated on a 4-point Likert scale. Total scores range from 16 to 64, with higher scores indicating greater fear of falling.

Before Treatment
Falls Efficacy Scale-International
Délai: 4 Week After Treatment

The Falls Efficacy Scale-International assesses concern about falling during daily activities. The scale consists of 16 items rated on a 4-point Likert scale. Total scores range from 16 to 64, with higher scores indicating greater fear of falling.

4 Week After Treatment
Functional Ambulation Category
Délai: Before Treatment

The Functional Ambulation Category is a 6-level scale that classifies ambulation ability based on the amount of physical assistance required. Higher levels indicate more independent walking performance.

Before Treatment
Functional Ambulation Category
Délai: 4 Week After Treatment

The Functional Ambulation Category is a 6-level scale that classifies ambulation ability based on the amount of physical assistance required. Higher levels indicate more independent walking performance.

4 Week After Treatment
Center of Pressure Standard Deviation
Délai: Before Treatment

Center of pressure variability during quiet standing will be assessed using the ProKin 252 posturography system (TecnoBody, Italy). Standard deviation of CoP displacement will be recorded as an indicator of postural stability. Lower values indicate better postural control.

Before Treatment
Center of Pressure Standard Deviation
Délai: 4 Week After Treatment

Center of pressure variability during quiet standing will be assessed using the ProKin 252 posturography system (TecnoBody, Italy). Standard deviation of CoP displacement will be recorded as an indicator of postural stability. Lower values indicate better postural control.

4 Week After Treatment
Center of Pressure Ellipse Area
Délai: Before Treatment

Static balance will be assessed using the ProKin 252 posturography system (TecnoBody, Italy). Center of pressure sway during quiet standing will be analyzed. Ellipse area (mm²) will be recorded as an indicator of postural stability. Lower values indicate better postural control.

Before Treatment
Center of Pressure Ellipse Area
Délai: 4 Week After Treatment

Static balance will be assessed using the ProKin 252 posturography system (TecnoBody, Italy). Center of pressure sway during quiet standing will be analyzed. Ellipse area (mm²) will be recorded as an indicator of postural stability. Lower values indicate better postural control.

4 Week After Treatment
Total Sway Perimeter
Délai: Before treatment

Static balance will be assessed using the ProKin 252 posturography system (TecnoBody, Italy). Center of pressure sway during quiet standing will be analyzed. Total sway perimeter (mm) will be recorded as an indicator of postural stability. Lower values indicate better postural control.

Before treatment
Total Sway Perimeter
Délai: 4 Week After Treatment

Static balance will be assessed using the ProKin 252 posturography system (TecnoBody, Italy). Center of pressure sway during quiet standing will be analyzed. Total sway perimeter (mm) will be recorded as an indicator of postural stability. Lower values indicate better postural control.

4 Week After Treatment
Dynamic Balance (Average Track Error)
Délai: Before treatment

Dynamic balance will be evaluated using the ProKin 252 platform-based proprioceptive control task. Movement accuracy will be quantified using average track error (%), representing the deviation from the target trajectory during the task. Lower values indicate better balance performance.

Before treatment
Dynamic Balance (Average Track Error)
Délai: 4 Week After Treatment

Dynamic balance will be evaluated using the ProKin 252 platform-based proprioceptive control task. Movement accuracy will be quantified using average track error (%), representing the deviation from the target trajectory during the task. Lower values indicate better balance performance.

4 Week After Treatment

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

15 mars 2026

Achèvement primaire (Réel)

15 août 2026

Achèvement de l'étude (Réel)

15 août 2026

Dates d'inscription aux études

Première soumission

10 mars 2026

Première soumission répondant aux critères de contrôle qualité

12 mars 2026

Première publication (Réel)

13 mars 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

4 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

2 novembre 2026

Dernière vérification

1 mars 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner